On November 4, Medline Inc. rose 7.8% in Pre-Market Trading, trading at $36.75/share, with turnover of $4.264 million.
The move followed a quarterly earnings release that exceeded market expectations on both profit and revenue.
For the fiscal third quarter, adjusted EPS was $0.44 versus the $0.35 consensus estimate, while sales reached $7.856 billion versus the $7.723 billion consensus. Net sales also increased from $7.12 billion a year earlier to $7.86 billion, indicating continued growth across its medical-surgical products and supply chain solutions businesses.
Recent context has been mixed: Medline had disclosed a broad removal or correction program for certain branded beds and accessories tied to fire and patient-entrapment risks, while it also introduced an enhanced TrackPoint system for long-term care providers in October. In the current session, however, the earnings beat appears to be the clearest direct catalyst for the stock’s pre-market strength.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments